However, a new finding in tumor biology reveals that sulfonyl HMGB1 exerted anti-inflammatory effects via the RAGE signaling pathway, which can recruit immune-competent cells and inhibit cytotoxic cells (11). Here, HMGB1 is linked to neoplasm.